Swiss National Bank
GMED icon

Swiss National Bank’s Globus Medical GMED Stock Holding History

Swiss National Bank’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1M Hold
222,077
– – 0.01% 676
2025
Q4 		$19.4M Buy
222,077
+3,200
+1% +$243K 0.01% 674
2025
Q3 		$12.5M Sell
218,877
-1,000
-0.5% -$57.6K 0.01% 840
2025
Q2 		$13M Sell
219,877
-400
-0.2% -$25.8K 0.01% 796
2025
Q1 		$16.1M Sell
220,277
-1,900
-0.9% -$157K 0.01% 676
2024
Q4 		$18.4M Buy
222,177
+2,200
+1% +$174K 0.01% 667
2024
Q3 		$15.7M Sell
219,977
-2,300
-1% -$162K 0.01% 726
2024
Q2 		$15.2M Sell
222,277
-5,500
-2% -$329K 0.01% 708
2024
Q1 		$12.2M Sell
227,777
-3,500
-2% -$188K 0.01% 826
2023
Q4 		$12.3M Sell
231,277
-30,100
-12% -$1.47M 0.01% 795
2023
Q3 		$13M Buy
261,377
+91,777
+54% +$5.13M 0.01% 774
2023
Q2 		$10.1M Buy
169,600
+2,500
+1% +$142K 0.01% 895
2023
Q1 		$9.46M Sell
167,100
-18,900
-10% -$1.21M 0.01% 896
2022
Q4 		$13.8M Sell
186,000
-2,000
-1% -$136K 0.01% 751
2022
Q3 		$11.2M Sell
188,000
-51,300
-21% -$3.09M 0.01% 829
2022
Q2 		$13.4M Buy
239,300
+52,400
+28% +$3.44M 0.01% 763
2022
Q1 		$13.8M Buy
186,900
+14,600
+8% +$1.01M 0.01% 826
2021
Q4 		$12.4M Buy
172,300
+800
+0.5% +$58.1K 0.01% 888
2021
Q3 		$13.1M Buy
171,500
+1,100
+0.6% +$88.3K 0.01% 868
2021
Q2 		$13.2M Sell
170,400
-3,800
-2% -$270K 0.01% 873
2021
Q1 		$10.7M Buy
174,200
+3,900
+2% +$247K 0.01% 963
2020
Q4 		$11.1M Buy
170,300
+500
+0.3% +$28.7K 0.01% 872
2020
Q3 		$8.41M Sell
169,800
-3,000
-2% -$155K 0.01% 883
2020
Q2 		$8.24M Buy
172,800
+23,500
+16% +$1.13M 0.01% 866
2020
Q1 		$6.35M Buy
149,300
+2,600
+2% +$128K 0.01% 812
2019
Q4 		$8.64M Buy
146,700
+2,700
+2% +$147K 0.01% 841
2019
Q3 		$7.36M Buy
144,000
+2,300
+2% +$110K 0.01% 892
2019
Q2 		$5.99M Buy
141,700
+3,200
+2% +$139K 0.01% 1005
2019
Q1 		$6.84M Buy
138,500
+7,000
+5% +$317K 0.01% 909
2018
Q4 		$5.69M Buy
131,500
+3,700
+3% +$185K 0.01% 913
2018
Q3 		$7.25M Buy
127,800
+1,700
+1% +$89.5K 0.01% 875
2018
Q2 		$6.36M Hold
126,100
– – 0.01% 948
2018
Q1 		$6.28M Buy
126,100
+2,800
+2% +$132K 0.01% 913
2017
Q4 		$5.07M Buy
123,300
+2,700
+2% +$94.5K 0.01% 1049
2017
Q3 		$3.58M Hold
120,600
– – ﹤0.01% 1239
2017
Q2 		$4M Buy
120,600
+2,700
+2% +$84.8K ﹤0.01% 1133
2017
Q1 		$3.49M Buy
117,900
+2,800
+2% +$76.4K ﹤0.01% 1214
2016
Q4 		$2.86M Hold
115,100
– – ﹤0.01% 1326
2016
Q3 		$2.6M Sell
115,100
-3,300
-3% -$77.6K ﹤0.01% 1338
2016
Q2 		$2.82M Hold
118,400
– – ﹤0.01% 1253
2016
Q1 		$2.71M Buy
118,400
+23,600
+25% +$577K 0.01% 1244
2015
Q4 		$2.64M Hold
94,800
– – 0.01% 1151
2015
Q3 		$1.96M Buy
94,800
+12,000
+14% +$304K 0.01% 1322
2015
Q2 		$2.13M Buy
82,800
+29,200
+54% +$739K 0.01% 1272
2015
Q1 		$1.35M Hold
53,600
– – ﹤0.01% 1568
2014
Q4 		$1.27M Buy
53,600
+2,800
+6% +$62K ﹤0.01% 1576
2014
Q3 		$999K Hold
50,800
– – ﹤0.01% 1669
2014
Q2 		$1.22M Sell
50,800
-5,800
-10% -$140K ﹤0.01% 1604
2014
Q1 		$1.5M Buy
56,600
+13,000
+30% +$309K 0.01% 1426
2013
Q4 		$880K Hold
43,600
– – ﹤0.01% 1615
2013
Q3 		$761K Sell
43,600
-9,500
-18% -$164K ﹤0.01% 1646
2013
Q2 		$895K Buy
+53,100
New +$819K ﹤0.01% 1504

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank's GMED Position: Q1 2026 in Review

Swiss National Bank held its Globus Medical (GMED) position steady in Q1 2026 at 222,077 shares worth $19.1M. The position accounts for 0.01% of the portfolio, ranked #676.

Swiss National Bank first reported a position in GMED in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.4M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Swiss National Bank held 222,077 shares of Globus Medical worth $19.1M as of Q1 2026.
  • Swiss National Bank left its Globus Medical share count unchanged in Q1 2026.
  • Globus Medical made up 0.01% of Swiss National Bank's portfolio in Q1 2026, its #676 holding.
  • Swiss National Bank first reported a position in Globus Medical in Q2 2013 and has held it in 52 quarters since.
  • Swiss National Bank's Globus Medical position peaked at $19.4M in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.